{"id":"NCT02250651","sponsor":"Allergan","briefTitle":"Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension","officialTitle":"The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-15","primaryCompletion":"2018-10-25","completion":"2020-07-22","firstPosted":"2014-09-26","resultsPosted":"2021-07-28","lastUpdate":"2021-07-28"},"enrollment":528,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Bimatoprost SR","otherNames":[]},{"type":"OTHER","name":"Sham: Applicator Without Needle","otherNames":[]},{"type":"DRUG","name":"Active Comparator: Timolol 0.5%","otherNames":[]},{"type":"DRUG","name":"Timolol Vehicle (placebo)","otherNames":[]}],"arms":[{"label":"Bimatoprost SR 15 μg","type":"EXPERIMENTAL"},{"label":"Bimatoprost SR 10 μg","type":"EXPERIMENTAL"},{"label":"Timolol 0.5%: Comparator","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.","primaryOutcome":{"measure":"Change From Baseline in Intraocular Pressure (IOP) in the Study Eye to Week 12 (Hours 0 and 2)","timeFrame":"Baseline (Up to 3 days prior to Day 1 at Hours 0 and 2) to Week 12 (Hours 0 and 2)","effectByArm":[{"arm":"Bimatoprost SR 15 μg","deltaMin":-6.47,"sd":0.3},{"arm":"Bimatoprost SR 10 μg","deltaMin":-6.18,"sd":0.3},{"arm":"Timolol 0.5%: Comparator","deltaMin":-6.11,"sd":0.3}],"pValues":[{"comp":"OG000 vs OG002","p":"0.3738"},{"comp":"OG001 vs OG002","p":"0.8514"},{"comp":"OG000 vs OG002","p":"0.0401"},{"comp":"OG001 vs OG002","p":"0.3621"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":4},"locations":{"siteCount":113,"countries":["United States","Argentina","Canada","Colombia","Czechia","Egypt","Germany","Italy","Malaysia","New Zealand","Singapore","South Africa","South Korea","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["36378864","35643967","34724172"],"seeAlso":["http://www.allerganclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":176},"commonTop":["Conjunctival hyperaemia","Corneal endothelial cell loss","Conjunctival haemorrhage","Eye pain","Foreign body sensation in eyes"]}}